CANTON, Mich.--(BUSINESS WIRE)--MMS, a data-focused Clinical Research Organization (CRO), announced MAPS Public Benefit Corporation (MAPS PBC) submitted a New Drug Application (NDA) to the FDA for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback